Subsequent anti‐myeloma therapy after maturation antigen ( <scp>BCMA</scp> ) chimeric antigen receptor ( <scp>CAR</scp> )‐T cell ( <scp>HDS269B</scp> ) treatment in patients with relapsed/refractory multiple myeloma

Authors :: Dongjian Chen
Xiaoxiang Wang
Zhi Chen
Songfu Jiang
Hua Jiang
Weijun Fu
Fang Xiang
Xuedong Sun
Juan Du
Source :: American Journal of Hematology. 97
Publication Year :: 2022
Publisher :: Wiley, 2022.

Tools